Hypothesis

We're proposing that antagonistic pleiotropy isn't a fixed trade‑but a tunable regulatory node where temporal patterning of signaling pathways determines whether early‑life benefits are coupled to late‑life costs. Specifically, pulsatile inhibition of mTORC1 during early adulthood can preserve its anabolic role for reproduction while preventing the chronic activation that drives senescence. If this decoupling works, lifespan can be extended without sacrificing fecundity.

Mechanistic Rationale

• Nutrient‑sensing circuits (mTOR, IGF‑1, AMPK) regulate both vitellogenesis and stress resistance. In C. elegans, the gene trl‑1 shifts resources to eggs by inhibiting vitellogenin, shortening life[[https://doi.org/10.1073/pnas.212031119]].
• It's known that chronic mTORC1 activity leads to lysosomal dysfunction and inflammaging, whereas transient mTORC1 pulses support protein synthesis needed for gametogenesis[[https://pmc.ncbi.nlm.nih.gov/articles/PMC9281621/]].
• Mathematical models of AP show that the strength of late‑life selection is negligible, allowing modifiers that alter the timing of pathway activity to persist if they boost early fitness[[https://augusta.elsevierpure.com/en/publications/is-antagonistic-pleiotropy-ubiquitous-in-aging-biology/]].

Testable Predictions

1. In C. elegans, administering rapamycin in short pulses (e.g., 4 h every 24 h) during the L4‑young adult window will increase brood size comparable to constitutive treatment while extending median lifespan >20 % relative to controls.
2. RNA‑seq of pulsed‑rapamycin worms will show sustained expression of vitellogenin‑related genes early and reduced expression of senescence markers (e.g., hsp‑16.2, gcs‑1) later.
3. In mice, intermittent mTORC1 inhibition (via intermittent fasting or rapamycin analogs) timed to early reproductive weeks will maintain litter size and increase late‑life survival, measured by frailty index.
4. Mathematical simulation incorporating a timing‑dependent AP parameter will predict a shift in the evolutionary stable strategy toward longer post‑reproductive lifespan when pulse amplitude exceeds a threshold derived from early‑life fecundity gains.

Potential Refutation

If pulsed mTORC1 inhibition fails to improve lifespan without reducing brood size, or if lifespan extension only occurs when early reproduction is compromised, the hypothesis that AP is a tunable trade‑would be falsified, supporting the view that senescence is an immutable byproduct of individual selection.